WEST PALM BEACH, FL, Dec. 30, 2020 (GLOBE NEWSWIRE) -- USA EQUITIES CORP. (OTCQB: USAQ) (the “Company,” “we,” or “our”) announced today that its revenues for the fourth quarter of 2020 would be approximately $120,000 and that its revenues would exceed $300,000 in the first quarter of 2021.

United States Equities Corp (Stock symbol USAQ) has been identified by Litchfield Hills Research as an "attractive" opportunity for those interested in the digital medicine space. With stocks currently trading under $1, the research group rates USAQ as a BUY with a target price of $5 per share.

Despite the uncertainty surrounding this vaccine, physicians can alleviate the patient's worry by providing an allergy test ahead of vaccination. Our AllergiEnd® tests empower the primary care practitioners to test and begin treating allergy patients in their own offices through a safe, easy to administer, needle-free skin test designed for administration in primary care settings.

USA Equities Corp. (OTCQB:USAQ) CEO Troy Grogan tells Proactive the group is gaining traction with its cloud-based software as a Medical Device system QHSLab, together with increased revenue growth from its distribution agreement with MedScience Research Group.

USA Equities Corp. and its wholly-owned subsidiary Medical Practice Income is proud to announce today that during the month of November the Company shipped its first revenue-producing allergy diagnostic products to its physician customers.

West Palm Beach, FL – November 13, 2020 –USA Equities Corp. (OTCQB: USAQ), and its wholly-owned subsidiary Medical Practice Income, a company focused on value-based healthcare solutions and physician-directed digital medicine, is proud to announce today, the equity research firm, Litchfield Hills Research LLC, released its first analyst coverage report on USAQ, rating the Company a "Buy" under its three-tiered (buy-hold-sell) rating system, with a target price of $5.00 per share.

USA EQUITIES CORP. (OTCQB: USAQ) (the “Company,” “we,” or “our”) and its wholly-owned subsidiary Medical Practice Income, announced an exclusive distribution agreement (the “Agreement”) with MedScience Research Group, Inc. (“MedScience”) today. MedScience granted the Company an exclusive right to distribute AllergiEnd®, its allergy diagnostics and allergen immunotherapy system, and related components (the “Products”) to physicians who are not allergy specialists.

West Palm Beach, FL – October 9th, 2020 – USA Equities Corp. (OTCQB: USAQ), a company focused on value-based healthcare solutions and physician-directed digital medicine, is proud to announce today, that its common stock was approved for quotation on the OTC Markets Group, Inc.’s OTCQB® tier Venture Market (the “OTCQB”).

USA Equities Corp. (USAQ), a company focused on value-based healthcare solutions and physician-directed digital medicine, is proud to announce that it has begun the application process for an up-list of its common stock to the OTCQB® Venture Marketplace.

West Palm Beach, FL, Sept. 01, 2020 (GLOBE NEWSWIRE) - Medical Practice Income (MPI), a subsidiary of USA Equities Corp. (OTC Link: USAQ), a company focused on value-based healthcare solutions and physician-directed digital medicine, is proud to announce the early success of the QHSLab launch in South Florida. Since launching the platform on June 30, 2020, 159 medical practices have provided 374 allergy patients with a QHSLab-generated allergen immunotherapy prescription, generating an estimated $664,608 in reimbursement revenue for these physician’s practices.

“I always encourage people who are interested in this space to really dive deeper than just the surface level of the industry as a whole. While the whole industry is booming, there are other segments of this market outpacing the industry as a whole - like the rollout of remote healthcare services like telemedicine and remote patient monitoring. As a result, we see this space positioned to triple in size over the next five years to more than $150 billion.” - Troy Grogan, CEO

So, why are we a publicly-traded company? The short answer is: transparency.

At Medical Practice Income, we believe that transparency with our clients, shareholders, and future companies that may want to acquire our technology is critical to the mission of our company.

West Palm Beach, FL, June 30, 2020 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTC Link: USAQ), a company focused on value-based healthcare solutions and physician-directed digital medicine, announced the launch of QHSLab, a Software as a Service (SaaS) platform today.

QHSLab will be brought to the marketplace through approximately 150 primary care practices in Florida. Physicians, nurse practitioners, and ancillary medical practice staff will be active users of this platform, utilizing its proprietary algorithm initially for selecting appropriate allergen immunotherapy treatment sets for their patient populations.